Literature DB >> 34027039

Zmat3 splices together p53-dependent tumor suppression.

Kathryn T Bieging-Rolett1, Laura D Attardi1,2,3.   

Abstract

The tumor protein p53 (TP53, best known as p53) transcription factor is a critical tumor suppressor, but those p53-inducible genes most important for tumor suppression have remained unclear. Using unbiased RNA interference and CRISPR (Clustered Regularly Interspersed Palindromic Repeats)/Cas9 (CRISPR-associated protein 9) screens, genetically engineered mouse models, human cancer genome analysis, and integrative eCLIP-sequencing and RNA-sequencing analyses, we reveal a new branch of p53-mediated tumor suppression involving the RNA splicing regulator Zinc finger Matrin-type 3, Zmat3.
© 2021 Taylor & Francis Group, LLC.

Entities:  

Keywords:  CRISPR screen; ZMAT3; p53; splicing; tumor suppression

Year:  2021        PMID: 34027039      PMCID: PMC8128213          DOI: 10.1080/23723556.2021.1898523

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  10 in total

1.  Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.

Authors:  Colleen A Brady; Dadi Jiang; Stephano S Mello; Thomas M Johnson; Lesley A Jarvis; Margaret M Kozak; Daniela Kenzelmann Broz; Shashwati Basak; Eunice J Park; Margaret E McLaughlin; Anthony N Karnezis; Laura D Attardi
Journal:  Cell       Date:  2011-05-13       Impact factor: 41.582

2.  Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity.

Authors:  B Bardot; R Bouarich-Bourimi; J Leemput; V Lejour; A Hamon; L Plancke; A G Jochemsen; I Simeonova; M Fang; F Toledo
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

3.  Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.

Authors:  Kathryn T Bieging-Rolett; Alyssa M Kaiser; David W Morgens; Anthony M Boutelle; Jose A Seoane; Eric L Van Nostrand; Changyu Zhu; Shauna L Houlihan; Stephano S Mello; Brian A Yee; Jacob McClendon; Sarah E Pierce; Ian P Winters; Mengxiong Wang; Andrew J Connolly; Scott W Lowe; Christina Curtis; Gene W Yeo; Monte M Winslow; Michael C Bassik; Laura D Attardi
Journal:  Mol Cell       Date:  2020-11-05       Impact factor: 17.970

4.  DNA repair processes are critical mediators of p53-dependent tumor suppression.

Authors:  Ana Janic; Liz J Valente; Matthew J Wakefield; Leon Di Stefano; Liz Milla; Stephen Wilcox; Haoyu Yang; Lin Tai; Cassandra J Vandenberg; Andrew J Kueh; Shinsuke Mizutani; Margs S Brennan; Robyn L Schenk; Lisa M Lindqvist; Anthony T Papenfuss; Liam O'Connor; Andreas Strasser; Marco J Herold
Journal:  Nat Med       Date:  2018-06-11       Impact factor: 53.440

Review 5.  p53 and Tumor Suppression: It Takes a Network.

Authors:  Anthony M Boutelle; Laura D Attardi
Journal:  Trends Cell Biol       Date:  2021-01-28       Impact factor: 20.808

6.  Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery.

Authors:  Marco Bezzi; Shun Xie Teo; Julius Muller; Wei Chuen Mok; Sanjeeb Kumar Sahu; Leah A Vardy; Zahid Q Bonday; Ernesto Guccione
Journal:  Genes Dev       Date:  2013-09-01       Impact factor: 11.361

7.  Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing.

Authors:  Sarah V Gerhart; Wendy A Kellner; Christine Thompson; Melissa B Pappalardi; Xi-Ping Zhang; Rocio Montes de Oca; Elayne Penebre; Kenneth Duncan; Ann Boriack-Sjodin; BaoChau Le; Christina Majer; Michael T McCabe; Chris Carpenter; Neil Johnson; Ryan G Kruger; Olena Barbash
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.379

8.  The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma.

Authors:  Bruna R Muys; Dimitrios G Anastasakis; Duncan Claypool; Lörinc Pongor; Xiao Ling Li; Ioannis Grammatikakis; Minxue Liu; Xiantao Wang; Kannanganattu V Prasanth; Mirit I Aladjem; Ashish Lal; Markus Hafner
Journal:  Genes Dev       Date:  2020-12-17       Impact factor: 11.361

9.  Genome-wide identification of Wig-1 mRNA targets by RIP-Seq analysis.

Authors:  Cinzia Bersani; Mikael Huss; Stefania Giacomello; Li-Di Xu; Julie Bianchi; Sofi Eriksson; Fredrik Jerhammar; Andrey Alexeyenko; Anna Vilborg; Joakim Lundeberg; Weng-Onn Lui; Klas G Wiman
Journal:  Oncotarget       Date:  2016-01-12

10.  Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity.

Authors:  Zdenek Andrysik; Matthew D Galbraith; Anna L Guarnieri; Sara Zaccara; Kelly D Sullivan; Ahwan Pandey; Morgan MacBeth; Alberto Inga; Joaquín M Espinosa
Journal:  Genome Res       Date:  2017-09-13       Impact factor: 9.043

  10 in total
  1 in total

1.  Craniofacial Defects in Embryos with Homozygous Deletion of Eftud2 in Their Neural Crest Cells Are Not Rescued by Trp53 Deletion.

Authors:  Marie-Claude Beauchamp; Alexia Boucher; Yanchen Dong; Rachel Aber; Loydie A Jerome-Majewska
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.